急性损伤的血液动力学管理
Daniel De Backer1, Rocio Rimachi1, Jacques Duranteau2
1Department of Intensive Care, CHIREC Hospitals, Université Libre de Bruxelles, Belgium.
Current opinion in critical care
|November 6, 2024
概括
急性损伤 (AKI) 的血液动力学管理可以改变 perfusion. 虽然一些干预措施可以改善输液,但它们对重症患者功能的影响是可变的.
科学领域:
- 临界护理医学 临界护理医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液动力学 血液动力学
背景情况:
- 危急病患者的急性损伤 (AKI) 可能涉及持续的 perfusion 异常.
- 评估输液干预往往依赖于替代品,如替代疗法发病率,由于有限的直接测量数据.
研究的目的:
- 审查血液动力学管理策略在患有急性损伤的重症患者中的作用.
- 讨论各种干预措施对 perfusion 和功能的影响.
主要方法:
- 关于急性损伤的血液动力学管理的文献综述.
- 干预措施的分析,包括流体管理,内,血管压缩剂和平均动脉压 (MAP) 目标.
主要成果:
- 输入液体可能无法预测地改善 perfusion;在特定患者中,提取液体可能是有益的.
- 诸如多布他明之类的内类药物可以在与心力衰竭相关的AKI中增强 perfusion,但败血症数据有限.
- 血管压缩剂,包括上腺素和血管压缩素衍生物,以及潜在的血管素,对结局有不同的影响.
- 最佳的MAP目标需要个性化,考虑诸如中央静脉和腹内压力等因素.
结论:
- 最近的研究澄清了血液动力学干预对AKI perfusion和功能的影响.
- 虽然许多干预措施可以增强输液,但它们对整体功能的影响不一致.
相关概念视频
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Dialysis
269
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
269
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Antihypertensive Drugs: Direct Renin Inhibitors
498
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
498
Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Introduction to Urinary System
2.2K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
2.2K


